Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clostridium Difficile
Pharma
Ferring becomes the first with a fecal microbiotica product
The FDA has signed off on Ferring's Rebyota, an enema-delivered therapy for C. difficile that can restore bacterial balance in the digestive system.
Kevin Dunleavy
Dec 1, 2022 11:00am
Seres taps Bacthera to make microbiome therapy at Lonza site
Nov 11, 2021 9:35am
Pfizer execs see blockbuster vaccines throughout pipeline
Sep 15, 2020 10:18am
Pfizer cans $500M staph vaccine after phase 2b trial failure
Jan 30, 2019 9:20am
Could a trio of new vaccines make up for Prevnar at Pfizer?
May 7, 2018 12:30pm
Pfizer R&D chief sees pipeline shots filling Prevnar decline
Apr 10, 2018 10:10am
